New Swiss devices law aligns with EU, adds country-specific provisions
This article was originally published in RAJ Devices
The Swiss government has aligned its national laws with the European Union’s amending medical devices legislation (Directive 2007/47/EC) and has also introduced some country-specific measures, all of which enter into force on 1 April1,2.
You may also be interested in...
The risk of psychiatric disorders with chloroquine and hydroxychloroquine-containing medicines received renewed attention in the EU after they were being used as potential treatments for COVID-19.
New UK guidance explains how clinical trial sponsors and investigator sites can ensure that trial monitors securely process data in electronic health record systems that do not have a restricted access functionality.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.